The study also found a "statistically significant reduction" in suicidal ideation from participants. The post New Ibogaine Study for Vets Finds Positive...
The move marks a departure from the firm's previous reliance on philanthropic funding. The post Lykos Therapeutics Secures $100M in Series A Funding,...
“Neuroplasticity and Psychedelics” is a live webinar event brought to you by Wondermed and Neuly. It will be held on Monday, January 15th at 3pm ET....
The firm is targeting the FDA’s 505(b)(2) pathway for a potentially expedited approval process. The post Silo Pharma Proceeds with Ketamine Implant for...
Dear Friends, Happy New Year from myself and all at the Beckley Foundation! 25 years ago this year, I made the decision to transform myself, from...
The company is a going concern, with a cumulative deficit of $4,132,349 as of August 31. The post PharmAla Biotech Reports Progress in Earnings appeared...
The firm managed to find adequate research funding over the year as sale talks emerged. The post Tryp Therapeutics Lowers Losses in 2023; Sees New Era...
PharmAla Biotech Holdings Inc. (CSE: MDMA) (OTC: PMBHF)released its audited financial statements in Canadian dollars for the year ended on August 31, 2023....
From Calibre Mining to Atha Energy, Mugglehead covered more than 1,500 stories in 2023 The post Mugglehead Magazine’s Top 10 Stories of 2023 appeared...
The global demographic shift, marked by a decline in birth rates and an increase in aging populations, has posed a significant strain on healthcare resources....